Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 2
R&D Momentum
77/100
Pipeline Velocity
39/100
Trial Completion Rate
84/100
Pipeline Concentration
44/100
Pipeline Freshness
54/100
Strategic Signals
Activity
Last 14 days
Long Covid: Study of Quality of Life, Clinical Evolution and Use of Care. Cohort in General Practice and General Population in Metropolitan France COVILEV Study
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects: Identification of Biomarkers, Response During Virus-induced Exacerbations, and Interaction With Bronchial Epithelial Cells
Comparative Controlled Clinical Trial of Two Pharmacological Treatments of Pedophilia
Pathogenic Study of Adult Immune Enteropathies
Crosstalk Between Mucosal-Associated Invariant T Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
Daycare Environmental Exposure to Cleaning Products and Respiratory Health in Young Children and Daycare Workers
Molecular Characterization for Understanding Biliary Atresia
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)